Acs Research - Theorylab

Early detection of cancer through screening reduces mortality from cancers of the colon and rectum, breast, uterine cervix, and lung (see https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines.html). Cancer mortality has declined in recent decades in part due to progress in cancer screening technologies, awareness, research, and the general population’s improved uptake in screening services. But far too many individuals for whom screening is recommended remain unscreened, and this situation has been aggravated by the substantial decline in cancer screening resulting from the COVID-19 pandemic. Moreover, the pandemic-related disruptions will likely exacerbate existing disparities in cancer screening and survival across groups of people who have systemically experienced social or economic obstacles to screening and care. Deana Baptiste, PhD, MPH—the American Cancer Society’s Director of Guideline Development Process—joined the TheoryLab podcast to talk about why cancer screening remains